"sourceName","targetId","targetname","cohortCount","pathwayCount","Step 1","Step 2","Step 3","Step 4","Step 5","Step 6","Step 7","Step 8","Step 9","Step 10","personCount","pathwayPercent","cohortPercent"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","","","","","","","","","",84,"12.41%","9.12%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Angiotensin Receptor Blocker (ARB) Use [NR]","","","","","","","","","",83,"12.26%","9.01%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","","","","","","","","","",79,"11.67%","8.58%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[CBJ] BetaBlocker","","","","","","","","","",70,"10.34%","7.60%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Diuretic-Potassium Sparing Use [NR]","","","","","","","","","",32,"4.73%","3.47%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[TUTORIAL] New users of Thiazide-like diuretics as first-line monotherapy for hypertension_231026","","","","","","","","","",26,"3.84%","2.82%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","[CBJ] BetaBlocker","","","","","","","","",16,"2.36%","1.74%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","[CBJ] BetaBlocker","","","","","","","","",16,"2.36%","1.74%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Angiotensin Receptor Blocker (ARB) Use [NR]","[CBJ] BetaBlocker","","","","","","","","",15,"2.22%","1.63%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Diuretic-Loop Use [NR]","","","","","","","","","",14,"2.07%","1.52%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Alpha-1 Blocker Use [NR]","","","","","","","","","",9,"1.33%","0.98%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Angiotensin Receptor Blocker (ARB) Use [NR]","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","","","","","","","","",7,"1.03%","0.76%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[CBJ] BetaBlocker","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","","","","","","","","",6,"0.89%","0.65%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[TUTORIAL] New users of Thiazide-like diuretics as first-line monotherapy for hypertension_231026","[CBJ] BetaBlocker","","","","","","","","",6,"0.89%","0.65%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Diuretic-Loop Use [NR]","","","","","","","","",6,"0.89%","0.65%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Diuretic-Loop Use [NR]","[CBJ] BetaBlocker","","","","","","","","",5,"0.74%","0.54%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Diuretic-Potassium Sparing Use [NR]","[CBJ] BetaBlocker","","","","","","","","",5,"0.74%","0.54%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Angiotensin Receptor Blocker (ARB) Use [NR] + Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","","","","","","","","","",5,"0.74%","0.54%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Angiotensin Receptor Blocker (ARB) Use [NR]","Diuretic-Loop Use [NR]","","","","","","","","",5,"0.74%","0.54%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Diuretic-Potassium Sparing Use [NR]","Diuretic-Loop Use [NR]","","","","","","","","",5,"0.74%","0.54%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[CBJ] BetaBlocker","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","","","","","","","","",5,"0.74%","0.54%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","","","","","","","","",5,"0.74%","0.54%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","","","","","","","","",5,"0.74%","0.54%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Angiotensin Receptor Blocker (ARB) Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","","","","","","","","",4,"0.59%","0.43%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[CBJ] BetaBlocker","Angiotensin Receptor Blocker (ARB) Use [NR]","","","","","","","","",4,"0.59%","0.43%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[TUTORIAL] New users of Thiazide-like diuretics as first-line monotherapy for hypertension_231026","Diuretic-Loop Use [NR]","","","","","","","","",4,"0.59%","0.43%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[CBJ] BetaBlocker","Diuretic-Loop Use [NR]","","","","","","","","",4,"0.59%","0.43%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Diuretic-Loop Use [NR]","","","","","","","","",4,"0.59%","0.43%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Angiotensin Receptor Blocker (ARB) Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","[CBJ] BetaBlocker","","","","","","","",3,"0.44%","0.33%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","[CBJ] BetaBlocker","Diuretic-Loop Use [NR]","","","","","","","",3,"0.44%","0.33%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Alpha-1 Blocker Use [NR]","","","","","","","","",3,"0.44%","0.33%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR]","","","","","","","","",3,"0.44%","0.33%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","[CBJ] BetaBlocker","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Alpha-1 Blocker Use [NR]","","","","","","",2,"0.30%","0.22%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Diuretic-Loop Use [NR]","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","","","","","","","","",2,"0.30%","0.22%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR] + Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","","","","","","","",2,"0.30%","0.22%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","[CBJ] BetaBlocker + Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","","","","","","","",2,"0.30%","0.22%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Alpha-1 Blocker Use [NR]","[CBJ] BetaBlocker","","","","","","","",2,"0.30%","0.22%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","[CBJ] BetaBlocker","Angiotensin Receptor Blocker (ARB) Use [NR]","","","","","","","",2,"0.30%","0.22%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Diuretic-Potassium Sparing Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","","","","","","","","",2,"0.30%","0.22%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Diuretic-Potassium Sparing Use [NR]","Alpha-1 Blocker Use [NR]","","","","","","","","",2,"0.30%","0.22%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Diuretic-Potassium Sparing Use [NR]","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","","","","","","","","",2,"0.30%","0.22%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR]","","","","","","","","",2,"0.30%","0.22%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[CBJ] BetaBlocker","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR] + Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR]","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","[CBJ] BetaBlocker","Diuretic-Loop Use [NR]","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Angiotensin Receptor Blocker (ARB) Use [NR]","Diuretic-Loop Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","[CBJ] BetaBlocker","Diuretic-Loop Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[TUTORIAL] New users of Thiazide-like diuretics as first-line monotherapy for hypertension_231026","Diuretic-Loop Use [NR] + [TUTORIAL] New users of Thiazide-like diuretics as first-line monotherapy for hypertension_231026","Diuretic-Loop Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Angiotensin Receptor Blocker (ARB) Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR] + Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","[CBJ] BetaBlocker","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Alpha-1 Blocker Use [NR]","Diuretic-Loop Use [NR]","[CBJ] BetaBlocker + Diuretic-Loop Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[TUTORIAL] New users of Thiazide-like diuretics as first-line monotherapy for hypertension_231026","Angiotensin Receptor Blocker (ARB) Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR] + [CBJ] BetaBlocker","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR] + Diuretic-Loop Use [NR]","Diuretic-Loop Use [NR]","[CBJ] BetaBlocker","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Diuretic-Loop Use [NR]","[CBJ] BetaBlocker + Diuretic-Loop Use [NR]","[CBJ] BetaBlocker","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Alpha-1 Blocker Use [NR]","[CBJ] BetaBlocker","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","[CBJ] BetaBlocker","Angiotensin Receptor Blocker (ARB) Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR] + Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR]","Diuretic-Loop Use [NR]","[CBJ] BetaBlocker + Diuretic-Loop Use [NR]","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Alpha-1 Blocker Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Angiotensin Receptor Blocker (ARB) Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR] + Alpha-1 Blocker Use [NR]","Alpha-1 Blocker Use [NR]","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Diuretic-Potassium Sparing Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Angiotensin Receptor Blocker (ARB) Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR] + Alpha-1 Blocker Use [NR]","Alpha-1 Blocker Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Angiotensin Receptor Blocker (ARB) Use [NR]","Diuretic-Loop Use [NR]","[CBJ] BetaBlocker","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Diuretic-Potassium Sparing Use [NR]","[CBJ] BetaBlocker","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[TUTORIAL] New users of Thiazide-like diuretics as first-line monotherapy for hypertension_231026","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR] + Diuretic-Potassium Sparing Use [NR]","Diuretic-Potassium Sparing Use [NR]","[CBJ] BetaBlocker","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Diuretic-Loop Use [NR]","[CBJ] BetaBlocker + Diuretic-Loop Use [NR]","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Diuretic-Potassium Sparing Use [NR]","[CBJ] BetaBlocker","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR] + Diuretic-Potassium Sparing Use [NR]","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","[CBJ] BetaBlocker + Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","[CBJ] BetaBlocker","Diuretic-Potassium Sparing Use [NR]","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Diuretic-Potassium Sparing Use [NR]","[CBJ] BetaBlocker","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Diuretic-Loop Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Diuretic-Loop Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR]","[CBJ] BetaBlocker","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[TUTORIAL] New users of Thiazide-like diuretics as first-line monotherapy for hypertension_231026","[CBJ] BetaBlocker","Angiotensin Receptor Blocker (ARB) Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR] + Diuretic-Loop Use [NR]","[CBJ] BetaBlocker + Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR] + Diuretic-Loop Use [NR]","Diuretic-Loop Use [NR]","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[TUTORIAL] New users of Thiazide-like diuretics as first-line monotherapy for hypertension_231026","[CBJ] BetaBlocker","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Angiotensin Receptor Blocker (ARB) Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR] + Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Diuretic-Loop Use [NR]","Diuretic-Loop Use [NR] + Alpha-1 Blocker Use [NR]","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Diuretic-Potassium Sparing Use [NR]","","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Diuretic-Potassium Sparing Use [NR]","[CBJ] BetaBlocker","Angiotensin Receptor Blocker (ARB) Use [NR] + Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Diuretic-Loop Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Diuretic-Loop Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Angiotensin Receptor Blocker (ARB) Use [NR]","[CBJ] BetaBlocker","Alpha-1 Blocker Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[CBJ] BetaBlocker","Diuretic-Potassium Sparing Use [NR]","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR] + Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Alpha-1 Blocker Use [NR]","Diuretic-Loop Use [NR]","[CBJ] BetaBlocker","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Angiotensin Receptor Blocker (ARB) Use [NR]","[CBJ] BetaBlocker","Diuretic-Loop Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[CBJ] BetaBlocker","Diuretic-Loop Use [NR]","[CBJ] BetaBlocker + Diuretic-Loop Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Angiotensin Receptor Blocker (ARB) Use [NR]","Diuretic-Loop Use [NR]","[CBJ] BetaBlocker","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Diuretic-Potassium Sparing Use [NR]","[CBJ] BetaBlocker","Angiotensin Receptor Blocker (ARB) Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR] + [CBJ] BetaBlocker","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[CBJ] BetaBlocker","Angiotensin Receptor Blocker (ARB) Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Angiotensin Receptor Blocker (ARB) Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR] + [CBJ] BetaBlocker","Angiotensin Receptor Blocker (ARB) Use [NR] + Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR] + [CBJ] BetaBlocker + Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Diuretic-Potassium Sparing Use [NR]","[CBJ] BetaBlocker + Diuretic-Potassium Sparing Use [NR]","[CBJ] BetaBlocker","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[CBJ] BetaBlocker","Diuretic-Potassium Sparing Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Angiotensin Receptor Blocker (ARB) Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Diuretic-Potassium Sparing Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR] + Diuretic-Potassium Sparing Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","[CBJ] BetaBlocker","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Alpha-1 Blocker Use [NR]","[CBJ] BetaBlocker","","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","[CBJ] BetaBlocker","Alpha-1 Blocker Use [NR]","Diuretic-Loop Use [NR] + Alpha-1 Blocker Use [NR]","[CBJ] BetaBlocker + Diuretic-Loop Use [NR] + Alpha-1 Blocker Use [NR]","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","[CBJ] BetaBlocker","Diuretic-Loop Use [NR]","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Diuretic-Loop Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR] + Diuretic-Loop Use [NR]","[CBJ] BetaBlocker + Diuretic-Loop Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR] + Diuretic-Loop Use [NR]","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","[CBJ] BetaBlocker + Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR] + Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","[CBJ] BetaBlocker","Alpha-1 Blocker Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Diuretic-Potassium Sparing Use [NR]","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","[CBJ] BetaBlocker","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","[CBJ] BetaBlocker + Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Diuretic-Loop Use [NR]","[CBJ] BetaBlocker + Diuretic-Loop Use [NR]","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Diuretic-Loop Use [NR]","[CBJ] BetaBlocker","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Angiotensin Receptor Blocker (ARB) Use [NR]","[CBJ] BetaBlocker","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","[CBJ] BetaBlocker + Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR] + Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[TUTORIAL] New users of Thiazide-like diuretics as first-line monotherapy for hypertension_231026","Diuretic-Loop Use [NR] + [TUTORIAL] New users of Thiazide-like diuretics as first-line monotherapy for hypertension_231026","","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[CBJ] BetaBlocker","Alpha-1 Blocker Use [NR]","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[TUTORIAL] New users of Thiazide-like diuretics as first-line monotherapy for hypertension_231026","[CBJ] BetaBlocker + [TUTORIAL] New users of Thiazide-like diuretics as first-line monotherapy for hypertension_231026","","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Diuretic-Loop Use [NR]","[CBJ] BetaBlocker","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Alpha-1 Blocker Use [NR] + Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[TUTORIAL] New users of Thiazide-like diuretics as first-line monotherapy for hypertension_231026","[CBJ] BetaBlocker + [TUTORIAL] New users of Thiazide-like diuretics as first-line monotherapy for hypertension_231026","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Alpha-1 Blocker Use [NR]","Diuretic-Potassium Sparing Use [NR]","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[TUTORIAL] New users of Thiazide-like diuretics as first-line monotherapy for hypertension_231026","Diuretic-Potassium Sparing Use [NR]","","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Angiotensin Receptor Blocker (ARB) Use [NR]","Alpha-1 Blocker Use [NR]","Alpha-1 Blocker Use [NR] + Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Alpha-1 Blocker Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","[CBJ] BetaBlocker + Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","[CBJ] BetaBlocker","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Angiotensin Receptor Blocker (ARB) Use [NR]","Diuretic-Potassium Sparing Use [NR]","[CBJ] BetaBlocker","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Diuretic-Loop Use [NR] + Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Diuretic-Loop Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[CBJ] BetaBlocker","Angiotensin Receptor Blocker (ARB) Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR] + [CBJ] BetaBlocker","Alpha-1 Blocker Use [NR]","[CBJ] BetaBlocker + Alpha-1 Blocker Use [NR]","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Diuretic-Loop Use [NR]","Alpha-1 Blocker Use [NR]","[CBJ] BetaBlocker","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR] + Alpha-1 Blocker Use [NR]","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","[CBJ] BetaBlocker","Diuretic-Potassium Sparing Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","[CBJ] BetaBlocker","Alpha-1 Blocker Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Angiotensin Receptor Blocker (ARB) Use [NR]","[CBJ] BetaBlocker","Diuretic-Potassium Sparing Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR] + Diuretic-Potassium Sparing Use [NR]","Diuretic-Potassium Sparing Use [NR]","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Diuretic-Potassium Sparing Use [NR]","Diuretic-Loop Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Diuretic-Potassium Sparing Use [NR]","[CBJ] BetaBlocker","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Angiotensin Receptor Blocker (ARB) Use [NR] + Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR] + [CBJ] BetaBlocker + Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","[CBJ] BetaBlocker","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Angiotensin Receptor Blocker (ARB) Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR] + [CBJ] BetaBlocker","Diuretic-Loop Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR] + Diuretic-Loop Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[CBJ] BetaBlocker","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Diuretic-Loop Use [NR]","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[CBJ] BetaBlocker","Angiotensin Receptor Blocker (ARB) Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Alpha-1 Blocker Use [NR]","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Diuretic-Loop Use [NR]","[CBJ] BetaBlocker","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Angiotensin Receptor Blocker (ARB) Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR] + Alpha-1 Blocker Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR] + Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Diuretic-Loop Use [NR]","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","[CBJ] BetaBlocker","Diuretic-Loop Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Diuretic-Loop Use [NR]","Diuretic-Potassium Sparing Use [NR]","","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","[CBJ] BetaBlocker","Diuretic-Potassium Sparing Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR] + Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","[CBJ] BetaBlocker","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR] + Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR] + Diuretic-Potassium Sparing Use [NR]","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","[CBJ] BetaBlocker + Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","[CBJ] BetaBlocker","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR] + Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[CBJ] BetaBlocker","Diuretic-Potassium Sparing Use [NR]","[CBJ] BetaBlocker + Diuretic-Potassium Sparing Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Angiotensin Receptor Blocker (ARB) Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR] + [CBJ] BetaBlocker","[CBJ] BetaBlocker","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","[CBJ] BetaBlocker + Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR] + Diuretic-Loop Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Diuretic-Potassium Sparing Use [NR]","Diuretic-Loop Use [NR]","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[CBJ] BetaBlocker","Alpha-1 Blocker Use [NR]","","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[CBJ] BetaBlocker","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","[CBJ] BetaBlocker + Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Diuretic-Loop Use [NR]","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[TUTORIAL] New users of Thiazide-like diuretics as first-line monotherapy for hypertension_231026","Diuretic-Loop Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Alpha-1 Blocker Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR]","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","[CBJ] BetaBlocker","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR] + Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","[CBJ] BetaBlocker","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR] + Diuretic-Potassium Sparing Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR] + Diuretic-Potassium Sparing Use [NR] + Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","[CBJ] BetaBlocker + Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR] + Diuretic-Potassium Sparing Use [NR] + Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR] + Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","[CBJ] BetaBlocker","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[TUTORIAL] New users of Thiazide-like diuretics as first-line monotherapy for hypertension_231026","Angiotensin Receptor Blocker (ARB) Use [NR]","","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR] + Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Diuretic-Potassium Sparing Use [NR]","[CBJ] BetaBlocker","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[TUTORIAL] New users of Thiazide-like diuretics as first-line monotherapy for hypertension_231026","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Angiotensin Receptor Blocker (ARB) Use [NR]","[CBJ] BetaBlocker","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Angiotensin Receptor Blocker (ARB) Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR] + [CBJ] BetaBlocker","","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[TUTORIAL] New users of Thiazide-like diuretics as first-line monotherapy for hypertension_231026","Alpha-1 Blocker Use [NR]","","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[CBJ] BetaBlocker","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","[CBJ] BetaBlocker + Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[TUTORIAL] New users of Thiazide-like diuretics as first-line monotherapy for hypertension_231026","Angiotensin Receptor Blocker (ARB) Use [NR] + [TUTORIAL] New users of Thiazide-like diuretics as first-line monotherapy for hypertension_231026","Angiotensin Receptor Blocker (ARB) Use [NR]","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Diuretic-Loop Use [NR]","[CBJ] BetaBlocker","","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Angiotensin Receptor Blocker (ARB) Use [NR]","Angiotensin Receptor Blocker (ARB) Use [NR] + [CBJ] BetaBlocker","Angiotensin Receptor Blocker (ARB) Use [NR] + Alpha-1 Blocker Use [NR]","Alpha-1 Blocker Use [NR]","[CBJ] BetaBlocker","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Alpha-1 Blocker Use [NR]","Diuretic-Loop Use [NR] + Alpha-1 Blocker Use [NR]","[CBJ] BetaBlocker","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","[CBJ] BetaBlocker","Diuretic-Potassium Sparing Use [NR]","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","[CBJ] BetaBlocker + Diuretic-Potassium Sparing Use [NR]","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"[TUTORIAL] New users of Thiazide-like diuretics as first-line monotherapy for hypertension_231026","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR] + [TUTORIAL] New users of Thiazide-like diuretics as first-line monotherapy for hypertension_231026","Alpha-1 Blocker Use [NR]","Diuretic-Loop Use [NR]","","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR] + Diuretic-Potassium Sparing Use [NR]","Diuretic-Potassium Sparing Use [NR]","[CBJ] BetaBlocker","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","","","","","",1,"0.15%","0.11%"
"SYNPUF 5%",1788133,"initiators of hypertensive treatment 1yr - maraloort",921,677,"Angiotensin Receptor Blocker (ARB) Use [NR]","Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR]","Dihydropyridine Calcium Channel Blocker (dCCB) Use [NR] + Non-Dihydropyridine Calcium Channel Blocker (ndCCB) Use [NR]","[CBJ] BetaBlocker","","","","","",1,"0.15%","0.11%"